| Authors: |
Mulic-Al Bunni S; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Gschwind M; Department of Neurology, Kantonsspital Aarau, Aarau, Switzerland.; Department of Clinical Neurosciences, University of Geneva, Geneva, Switzerland., Finkener S; Department of Neurology, Kantonsspital Aarau, Aarau, Switzerland., Al-Diwani A; Department of Psychiatry, University of Oxford, Oxford, UK., Easton A; Encephalitis International, Malton, UK.; Department of Clinical Infection, Microbiology, and Immunology, University of Liverpool, Liverpool, UK., Handel AE; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.; Department of Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Binks SNM; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. sophie.binks@ndcn.ox.ac.uk.; Department of Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. sophie.binks@ndcn.ox.ac.uk. |
